News about SNCA. Major catalysts and much more.
“Leading BioSciences Announces FDA Fast Track Designation Granted to LB1148 for the Treatment of Postoperative Gastrointestinal Dysfunction Associated with Pediatric Cardiovascular Surgery.”

“Seneca Biopharma, Inc. Announces Top-Line Data from Phase 2 Clinical Study in China for the Treatment of Ischemic Stroke.”

“Seneca Biopharma Regains Compliance with NASDAQ Listing Requirements.”

With all of the successes that this company is having and the upcoming merger that is set to take place, I believe that in the near future, SNCA will rise to greater heights.
https://www.reddit.com/r/StockMarket/comments/lh1dhh/news_about_snca_major_catalysts_and_much_more/